Inserm
Records under this name other than the patents Inserm holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,765,723 | Use of Low Dose IL-2 for Treating Autoimmune - Related or Inflammatory Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,072,077 | Novel Antibody Useful in Neurological or Neurodegenerative Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,444,228 | Method of screening a candidate compound for inducing bile canalicular function disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,172,961 | Inhibitors of Fusion Between Viral and Cell Membranes as Well as Compositions and Methods of Using Them Formerly held In force · High confidence | In force | High confidence | |
| US 11,643,639 | Skin Reconstruction Method Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,918,647 | Selective Bromodomain Inhibition of Fungal BDF1 Formerly held In force · High confidence | In force | High confidence | |
| US 10,106,801 | Auto-Inducible Expression System Lapsed on the fee record Ended Oct 23, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 23, 2026 | Low confidence |
| US 11,448,656 | Compositions Useful in the Diagnostic of Latently Infected Mycobacterium Tuberculosis Lapsed on the fee record Ended Sep 20, 2026 · Low confidence | Lapsed on the fee record | Ended Sep 20, 2026 | Low confidence |
| US 11,389,434 | Methods and Pharmaceutical Compositions for the Treatment of Mast Cell Diseases Lapsed on the fee record Ended Jul 19, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 19, 2026 | Medium confidence |
| US 7,713,203 | Ultrasound treatment device and method Term ended Term ended May 16, 2026 · From the USPTO record | Term ended | Term ended May 16, 2026 | From the USPTO record |